O-37 - Skin, Soft Tissue, Bone & Joint Infections

Co-Author(s)

• SB

  Samantha Bagsic, PhD, MSE

  Biostatistician
  Scripps Health
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CB

  Clothilde Bettinger, n/a

  MD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• jB

  jérôme Bourlet, n/a

  MD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PC

  Philippe Céruse, n/a

  MD, PhD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Laura Certain, MD, PhD

  Assistant Professor, Infectious Diseases
  University of Utah
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• Fc

  Fabien craighero, n/a

  MD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Michael Dagher, MD

  Research Scholar
  Division of Infectious Diseases, Department of Internal Medicine
  Duke University Medical Center
  Durham, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CD

  Clémentine Daveau, n/a

  MD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CD

  Céline Dupieux-Chabert, n/a

  MD, PhD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• TF

  Tristan Ferry, MD, PhD

  Prof.
  Infectious diseases
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Vance Fowler, Jr., MD, MHS

  Professor of Medicine
  Division of Infectious Diseases
  Duke University
  Durham, North Carolina

  Disclosure: Abbvie : Grant/Research Support (Status: Ongoing); Actavis : Grant/Research Support; Advanced Liquid Logics : Grant/Research Support; Affinergy : Consultant, Research Grant or Support; Affinium : Consultant; Allergan : Grant/Research Support; Ampliphi Biosciences : Consultant; Armata : Consultant (Status: Ongoing); Basilea : Consultant, Research Grant or Support; Bayer : Consultant, Consultant; C3J : Consultant; CARB-X : Consultant (Status: Ongoing); Cerexa : Consultant, Research Grant or Support; Contrafect : Consultant, Research Grant or Support; Cubist : Grant/Research Support; Debiopharm : Consultant; Destiny : Consultant; Durata : Consultant; Forest : Grant/Research Support; Genentech : Consultant, Research Grant or Support; ICBiome : Consultant (Status: Ongoing); Integrated Biotherapeutics : Consultant; Janssen : Consultant, Research Grant or Support; Karius : Grant/Research Support; Locus : Grant/Research Support; Medical Biosurfaces : Grant/Research Support; Medicines Co. : Consultant; Medimmune : Consultant, Research Grant or Support; Merck : Consultant, Research Grant or Support; NIH : Grant/Research Support; Novadigm : Consultant; Novartis : Consultant, Research Grant or Support; Pfizer : Grant/Research Support; Regeneron : Consultant, Research Grant or Support; Tetraphase : Consultant; Theravance : Consultant, Research Grant or Support; Valanbio : Board Member (Status: Ongoing), Other Financial or Material Support (Status: Ongoing), Stock options (Status: Ongoing); xBiotech : Consultant
• CF

  Carine Fuchsmann, n/a

  MD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MG

  Miguel Goicoechea, MD

  Head, Division of Infectious Diseases
  Infectious Diseases
  Scripps Health
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SJ

  Scott Johns, PharmD

  Clinical Pharmacist
  Pharmacy/Infectious Diseases
  San Diego VA Healthcare System
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• TK

  Thomas Kozak, MD

  Head, Division of Urgent Care
  Urgent Care
  Scripps Green Hospital
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AM

  Ariel Ma, PharmD

  ID Pharmacist
  Pharmacy
  VA San Diego Medical Center
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SM

  Stacey Mascarinec, MD, PhD

  Assistant Professor of Medicine
  Division of Infectious Diseases, Department of Medicine
  Duke University Medical Center
  Durham, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LP

  Larry Park, PhD

  Associate Professor
  Duke University Department of Medicine
  Durham, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JP

  Jakrapun Pupaibool, MD

  Assistant Professor
  Infectious Diseases
  University of Utah School of Medicine
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• FR

  Felicia Ruffin, MSN

  Research Program Leader
  Department of Medicine/Infectious Diseases
  Duke University Medical Center
  Durham, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NS

  Nicolas Sigaux, n/a

  MD, PhD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• FV

  Florent Valour, MD, PhD

  Dr
  Infectious disease department, CRIOAc Lyon (reference center for complex BJI management), Claude Bernard Lyon 1 University / UCSF
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  J. Alex Viehman, MD

  Clinical Assistant Professor
  Infectious Diseases
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

• 

  Aryn Andrzejewski, MD

  Internal Medicine Resident PGY-3
  Internal Medicine
  University of Pittsburgh Medical Center
  Pittsburgh, PA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Lauren Dea, PharmD

  PGY2 ID Pharmacy Resident
  VA San Diego , CA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• Cj

  Clément javaux, n/a

  MD
  Hospices Civils de Lyon
  Lyon, Rhone-Alpes, France

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Tori Kinamon

  Medical Student
  School of Medicine
  Duke University
  Durham, NC

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Eugene Lee, MD

  Fellow physician
  Infectious Disease
  University of Utah
  Tumwater, WA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Laya Reddy, MD

  Physician
  Scripps Health
  San Diego, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio

Presentations:

• The Role of Bone Pathology in the Management of Residual Osteomyelitis After Amputation for Diabetic Foot Infections
  Eugene Lee, MD – University of Utah; Jakrapun Pupaibool, MD – University of Utah School of Medicine; Laura Certain, MD, PhD – University of Utah
• Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with staphylococcus Aureus Bacteremia: Results from a 20-year Prospective Cohort
  Michael M. Dagher, MD – Duke University Medical Center; Tori Kinamon – Duke University; Felicia Ruffin, MSN – Duke University Medical Center; Larry Park, PhD – Duke University Department of Medicine; Stacey Mascarinec, MD, PhD – Duke University Medical Center; Vance G. Fowler, Jr., MD, MHS – Duke University
• Osteomyelitis Following Mandibular Reconstruction with Free Fibula Flap: A Cohort Study of an Emerging and Complex Bone and Joint Infection
  Clément javaux, n/a – Hospices Civils de Lyon; Clémentine Daveau, n/a – Hospices Civils de Lyon; Clothilde Bettinger, n/a – Hospices Civils de Lyon; jérôme Bourlet, n/a – Hospices Civils de Lyon; Céline Dupieux-Chabert, n/a – Hospices Civils de Lyon; Fabien craighero, n/a – Hospices Civils de Lyon; Carine Fuchsmann, n/a – Hospices Civils de Lyon; Philippe Céruse, n/a – Hospices Civils de Lyon; Nicolas Sigaux, n/a – Hospices Civils de Lyon; Tristan Ferry, MD, PhD – Infectious diseases; Florent Valour, MD, PhD – Infectious disease department, CRIOAc Lyon (reference center for complex BJI management), Claude Bernard Lyon 1 University / UCSF
• oral versus Intravenous Antibiotic Treatment in Skin and Soft Tissue Infections as a Consequence of Intravenous Drug Use: A Retrospective Study to Demonstrate Noninferiority
  Aryn M. Andrzejewski, MD – University of Pittsburgh Medical Center; J. Alex Viehman, MD – University of Pittsburgh
• The Use of Area Under the Curve to Determine Therapeutic Vancomycin Dosing in Skin and Soft Tissue Infections
  Lauren Dea, PharmD – VA San Diego; Scott T. Johns, PharmD – San Diego VA Healthcare System; Ariel Ma, PharmD – VA San Diego Medical Center
• Quality Improvement Initiative for Non-Purulent Cellulitis Management in Urgent Care Setting: Provider-level Performance Feedback
  Laya Reddy, MD – Scripps Health; Miguel Goicoechea, MD – Scripps Health; Thomas Kozak, MD – Scripps Green Hospital; Samantha Bagsic, PhD, MSE – Scripps Health